IRCT20230622058559N1
Recruiting
Phase 3
The Effect of Oral Nutritional protein Supplement on Nutritional Status and protein energy wasting of Hemodialysis Patients : a randomized double-blind, placebo-controlled trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 52
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •20\-70 years
- •albumin\<4gr/dl
- •the patient under hemodialysis from 6 months ago (at least 2 times in a week)
- •malnutrition based on must score\>1
Exclusion Criteria
- •lack of informed consent for participating
- •history of chronic diseases such as liver diseases, malignancies, severe cardiopulmonary diseases
- •history of any surgery within past 3 months
- •history of hospitalization due to malignancies within past 3 months
- •history of allergy due to oral nutritional supplements
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Effect of oral nutrition supplement enriched with eicosapentaenoic acid (Prosure) on inflammatory response following colon cancer surgery: A Phase II randomized controlled studyColon CancerJPRN-UMIN000008434agoya City University100
Recruiting
Not Applicable
The effect of oral nutritional supplement (ONS) on the prognostic nutritional index (PNI) during neoadjuvant chemotherapy for gastric cancergastric cancerJPRN-UMIN000012598ara Medical University40
Recruiting
Not Applicable
The survey of effects of oral nutrition supplements on an intake compliance in acute phasesAfter surgery, after acute illness and COVID-19 infectionJPRN-UMIN000049866Hitachi General Hospital60
Completed
Not Applicable
Analysis of the effect of oral nutritional supplement or branched chain amino acid (BCAA) on liver cirrhotic patients with less than 3.5 g/dl of serum albumin level.JPRN-UMIN000011183Kanazawa Medical University40
Completed
Not Applicable
Effect of an oral nutritional supplement therapy on muscle mass, bone metabolism, body composition, growth, and disease activity in pediatric Crohn’s Disease: a controlled trialDRKS00010278Klinikum der Universität München, Campus Großhadern42